{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:57Z","timestamp":1792806057830,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04422-5","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:31:37Z","timestamp":1780572697000},"page":"5384-5396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pressurised intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases: a scoping review of clinical evidence across emerging indications"],"prefix":"10.1007","volume":"28","author":[{"given":"Carlota P\u00e9rez","family":"Carpio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5413-8449","authenticated-orcid":false,"given":"Pablo Lozano","family":"Lominchar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Gonz\u00e1lez","family":"Bay\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"4422_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/bjs.8679","volume":"99","author":"J Segelman","year":"2012","unstructured":"Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99:699\u2013705.","journal-title":"Br J Surg"},{"key":"4422_CR2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, de Hingh IH, Bosscha K, Lemmens VE, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622\u20138.","journal-title":"Int J Cancer"},{"key":"4422_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nrc1611","volume":"5","author":"H Naora","year":"2005","unstructured":"Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer. 2005;5:355\u201366.","journal-title":"Nat Rev Cancer"},{"key":"4422_CR4","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426\u201332.","journal-title":"Ann Surg Oncol"},{"key":"4422_CR5","first-page":"1","volume":"62","author":"RL Dedrick","year":"1978","unstructured":"Dedrick RL, Myers CE, Bungay PM, DeVita VT. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep. 1978;62:1\u201311.","journal-title":"Cancer Treat Rep"},{"key":"4422_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep29999","volume":"6","author":"B Laforce","year":"2016","unstructured":"Laforce B, Bohic S, Dumas P, Simionovici A, Sch\u00fctz G, Vilgrain V, et al. Assessment of ovarian cancer tumors treated with intraperitoneal cisplatin therapy by nanoscopic X-ray fluorescence imaging. Sci Rep. 2016;6:29999. https:\/\/doi.org\/10.1038\/srep29999.","journal-title":"Sci Rep"},{"issue":"2","key":"4422_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4251\/wjgo.v2.i2.68","volume":"2","author":"S Gonz\u00e1lez-Moreno","year":"2010","unstructured":"Gonz\u00e1lez-Moreno S, Gonz\u00e1lez-Bay\u00f3n LA, Ortega-P\u00e9rez G. Hyperthermic intraperitoneal chemotherapy: rationale and technique. World J Gastrointest Oncol. 2010;2(2):68\u201375. https:\/\/doi.org\/10.4251\/wjgo.v2.i2.68.","journal-title":"World J Gastrointest Oncol"},{"key":"4422_CR8","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26:1849\u201355.","journal-title":"Surg Endosc"},{"key":"4422_CR9","first-page":"4478","volume":"50","author":"Y Boucher","year":"1990","unstructured":"Boucher Y, Baxter LT, Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res. 1990;50:4478\u201384.","journal-title":"Cancer Res"},{"key":"4422_CR10","first-page":"934","volume":"260","author":"MA Reymond","year":"2014","unstructured":"Reymond MA, Hu B, Garcia A, Ranjbar S, Zhao P, Moll R, et al. Feasibility of therapeutic aerosol delivery in surgical pneumoperitoneum - an ex vivo and in vivo study. Ann Surg. 2014;260:934\u201340.","journal-title":"Ann Surg"},{"key":"4422_CR11","first-page":"4180","volume":"30","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Falkenstein TA, Diaz-Carballo D, Forster E, Osma A, et al. Evaluating the effect of micropump position, stainless steel and titanium nozzle and application time on distribution in a PIPAC setting. Surg Endosc. 2016;30:4180\u20134.","journal-title":"Surg Endosc"},{"key":"4422_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/bjs\/znac284","volume":"110","author":"AE Baggaley","year":"2023","unstructured":"Baggaley AE, Grass F, Lurvink RJ, Rovers KP, Reymond MA, Lehmann K, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): updated systematic review using the IDEAL framework. Br J Surg. 2023;110:10\u20137.","journal-title":"Br J Surg"},{"key":"4422_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/pp-2020-0151","volume":"6","author":"A Taibi","year":"2021","unstructured":"Taibi A, Sgarbura O, Hubner M, Alyami M, Dumont F, Villeneuve L, et al. The ISSPP PIPAC database: design, process, access, and first interim analysis. Pleura Peritoneum. 2021;6:131\u20139.","journal-title":"Pleura Peritoneum"},{"key":"4422_CR14","volume":"4","author":"W Solass","year":"2019","unstructured":"Solass W, Sempoux C, Detlefsen S, Carr NJ, Reymond MA. Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS). Pleura Peritoneum. 2019;4:20190002.","journal-title":"Pleura Peritoneum"},{"key":"4422_CR15","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1245\/s10434-022-13010-0","volume":"30","author":"M Graversen","year":"2023","unstructured":"Graversen M, Detlefsen S, Pfeiffer P, Mortensen MB, et al. Treatment of peritoneal metastasis with pressurized intraperitoneal aerosol chemotherapy: results from the prospective PIPAC-OPC2 study. Ann Surg Oncol. 2023;30:1749\u201359.","journal-title":"Ann Surg Oncol"},{"key":"4422_CR16","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","volume":"20","author":"M Alyami","year":"2019","unstructured":"Alyami M, Hubner M, Grass F, Villeneuve L, Passot G, Glehen O, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20:e368\u201377.","journal-title":"Lancet Oncol"},{"key":"4422_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041125","volume":"15","author":"A Di Giorgio","year":"2023","unstructured":"Di Giorgio A, Cardini SA, Rotolo S, Amore Bonapasta S, Biacchi D, Petrucciani N, et al. 10 years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis. Cancers Basel. 2023;15:1125.","journal-title":"Cancers Basel"},{"key":"4422_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373.","journal-title":"Ann Intern Med"},{"key":"4422_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ejso.2021.10.028","volume":"48","author":"F Grass","year":"2022","unstructured":"Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hubner M, et al. Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: technical aspects and treatment protocols. Eur J Surg Oncol. 2022;48:789\u201394.","journal-title":"Eur J Surg Oncol"},{"key":"4422_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051060","volume":"13","author":"F Dumont","year":"2021","unstructured":"Dumont F, Passot C, Raoul JL, Kepenekian V, Lelievre B, Vaudoyer D, et al. A phase I dose escalation study of oxaliplatin, cisplatin and doxorubicin applied as PIPAC in patients with peritoneal carcinomatosis. Cancers Basel. 2021;13:1060.","journal-title":"Cancers Basel"},{"key":"4422_CR21","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-20-2152","volume":"27","author":"M Graversen","year":"2021","unstructured":"Graversen M, Detlefsen S, Pfeiffer P, Lundell L, Mortensen MB. PIPAC-OX: A phase I study of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy in patients with peritoneal metastases. Clin Cancer Res. 2021;27:1875\u201381.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4422_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1515\/pp-2023-0014","volume":"8","author":"S Detlefsen","year":"2023","unstructured":"Detlefsen S, Mortensen MB, Pfeiffer P, Lundell L, Graversen M. Peritoneal regression grading score (PRGS): first evidence for independent predictive and prognostic significance. Pleura Peritoneum. 2023;8(2):55\u201363.","journal-title":"Pleura Peritoneum"},{"key":"4422_CR23","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","volume":"20","author":"W Solass","year":"2013","unstructured":"Solass W, Giger-Pabst U, Zieren J, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann Surg Oncol. 2013;20:3504\u201311.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"4422_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110312","volume":"51","author":"E Burke","year":"2025","unstructured":"Burke E, et al. Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for peritoneal malignancy, a systematic review of its occupational safety. Eur J Surg Oncol. 2025;51(10):110312. https:\/\/doi.org\/10.1016\/j.ejso.2025.110312. (Epub 2025 Jul 5. PMID: 40651455.).","journal-title":"Eur J Surg Oncol"},{"key":"4422_CR25","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1245\/s10434-023-13941-2","volume":"30","author":"M Raoof","year":"2023","unstructured":"Raoof M, Blakely AM, Eng OS, Engstrom BI, Dineen SP, et al. Safety and efficacy of oxaliplatin pressurized intraperitoneal aerosolized chemotherapy (PIPAC) in colorectal and appendiceal cancer with peritoneal metastases: results of a multicenter phase I trial in the USA. Ann Surg Oncol. 2023;30:6606\u201316.","journal-title":"Ann Surg Oncol"},{"key":"4422_CR26","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15980-9","author":"MT Waheed","year":"2024","unstructured":"Waheed MT, et al. Impact of PIPAC-Oxaliplatin on functional recovery, good days, and survival in refractory colorectal and appendiceal carcinomatosis. Ann Surg Oncol. 2024. https:\/\/doi.org\/10.1245\/s10434-024-15980-9.","journal-title":"Ann Surg Oncol"},{"key":"4422_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108487","author":"P Rauwerdink","year":"2024","unstructured":"Rauwerdink P, et al. First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II). Eur J Surg Oncol. 2024. https:\/\/doi.org\/10.1016\/j.ejso.2024.108487.","journal-title":"Eur J Surg Oncol"},{"key":"4422_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-024-11185-z","author":"VCJ van de Vlasakker","year":"2024","unstructured":"van de Vlasakker VCJ, et al. Patient-reported outcomes during first-line palliative systemic therapy alternated with pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases. Surg Endosc. 2024. https:\/\/doi.org\/10.1007\/s00464-024-11185-z.","journal-title":"Surg Endosc"},{"key":"4422_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","volume":"20","author":"G Nadiradze","year":"2016","unstructured":"Nadiradze G, Giger-Pabst U, Zieren J, Strumberg D, Solass W, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis. J Gastrointest Surg. 2016;20:367\u201373.","journal-title":"J Gastrointest Surg"},{"key":"4422_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","volume":"132","author":"CB Tempfer","year":"2014","unstructured":"Tempfer CB, Celik I, Solass W, Buber T, Giger-Pabst U, Zieren J, et al. Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer. Gynecol Oncol. 2014;132:307\u201311.","journal-title":"Gynecol Oncol"},{"key":"4422_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","volume":"137","author":"CB Tempfer","year":"2015","unstructured":"Tempfer CB, Winnekendonk G, Giger-Pabst U, Solass W, Rezniczek GA, Zieren J, et al. Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin in women with peritoneal carcinosis: a cohort study. Gynecol Oncol. 2015;137:223\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2015.02.009.","journal-title":"Gynecol Oncol"},{"key":"4422_CR32","unstructured":"PIPAC-OPC1: Pressurized intraperitoneal aerosol chemotherapy for ovarian cancer. ClinicalTrials.gov identifier: NCT02320448."},{"issue":"2","key":"4422_CR33","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1245\/s10434-023-14648-0","volume":"31","author":"G Vizzielli","year":"2024","unstructured":"Vizzielli G, Chiantera V, Valentini AL, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) applied to platinum-resistant recurrence of ovarian tumor (PARROT trial). Ann Surg Oncol. 2024;31(2):1207\u201316.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4422_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1245\/s10434-025-18432-0","volume":"33","author":"B Nakamura","year":"2026","unstructured":"Nakamura B, Raoof M, Whelan RL, et al. Safety and efficacy of cisplatin and doxorubicin PIPAC in patients with ovarian cancer with peritoneal metastases: a multicenter US phase I trial. Ann Surg Oncol. 2026;33(1):415\u201325.","journal-title":"Ann Surg Oncol"},{"key":"4422_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/cancers18020182","volume":"18","author":"N Ganatra","year":"2026","unstructured":"Ganatra N, et al. Intraperitoneal chemotherapy strategies in pancreatic ductal adenocarcinoma: a systematic review. Cancers. 2026;18:182.","journal-title":"Cancers"},{"key":"4422_CR36","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1245\/s10434-023-13572-7","volume":"30","author":"F Casella","year":"2023","unstructured":"Casella F, Bencivenga M, Brancato G, Torroni L, Ridolfi C, Puccio C, et al. Bidirectional approach with PIPAC and systemic chemotherapy for patients with synchronous gastric cancer peritoneal metastases (GCPM). Ann Surg Oncol. 2023;30:5733\u201342.","journal-title":"Ann Surg Oncol"},{"key":"4422_CR37","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-13572-7","author":"A Bianchi","year":"2025","unstructured":"Bianchi A, et al. Bidirectional PIPAC and systemic chemotherapy for conversion surgery in gastric cancer peritoneal metastases: a Western Phase II study. Ann Surg Oncol. 2025. https:\/\/doi.org\/10.1245\/s10434-023-13572-7.","journal-title":"Ann Surg Oncol"},{"key":"4422_CR38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1186\/s13063-022-06880-y","volume":"23","author":"A Di Giorgio","year":"2022","unstructured":"Di Giorgio A, Sgarbura O, Rotolo S, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne. Trials. 2022;23:789.","journal-title":"Trials"},{"issue":"2","key":"4422_CR39","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2018-0107","volume":"3","author":"M Graversen","year":"2018","unstructured":"Graversen M, Detlefsen S, Bjerregaard JK, Pfeiffer P, Mortensen MB. Adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) in resected high-risk colon cancer patients - study protocol for the PIPAC-OPC3 trial. Pleura Peritoneum. 2018;3(2):20180107.","journal-title":"Pleura Peritoneum"},{"issue":"2","key":"4422_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1515\/pp-2016-0005","volume":"1","author":"MA Reymond","year":"2016","unstructured":"Reymond MA, Solass W. In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC). Pleura Peritoneum. 2016;1(2):109\u201316.","journal-title":"Pleura Peritoneum"},{"issue":"5","key":"4422_CR41","doi-asserted-by":"publisher","first-page":"111731","DOI":"10.1016\/j.ejso.2026.111731","volume":"52","author":"D Zambrano","year":"2026","unstructured":"Zambrano D, Sgarbura O, Passot G, et al. Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120 mg\/m2): MINOS real-life multicenter study. Eur J Surg Oncol. 2026;52(5):111731. https:\/\/doi.org\/10.1016\/j.ejso.2026.111731. (Epub ahead of print. PMID: 41830675).","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"4422_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103681","volume":"9","author":"R Sundar","year":"2024","unstructured":"Sundar R, Kepenekian V, Gelli M, et al. Phase I PIANO trial - PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases. ESMO Open. 2024;9(9):103681.","journal-title":"ESMO Open"},{"issue":"3","key":"4422_CR43","doi-asserted-by":"publisher","first-page":"20180114","DOI":"10.1186\/ISRCTN17575409","volume":"3","author":"C Bachmann","year":"2018","unstructured":"Bachmann C, Kramer B, Strotgen A, Schott S, et al. PIPAC-OV3: a multicenter, open-label, randomized, two-arm phase III trial. Pleura Peritoneum. 2018;3(3):20180114. https:\/\/doi.org\/10.1186\/ISRCTN17575409.","journal-title":"Pleura Peritoneum"},{"key":"4422_CR44","doi-asserted-by":"publisher","unstructured":"PICCOS Trial: Pressurized intraperitoneal chemotherapy in colorectal and other cancers study. cancer research UK, University of Birmingham. ISRCTN registered, 2024.ISRCTN17575409 https:\/\/doi.org\/10.1186\/ISRCTN17575409","DOI":"10.1186\/ISRCTN17575409"},{"key":"4422_CR45","doi-asserted-by":"publisher","DOI":"10.2196\/78053","volume":"14","author":"A Kerimkulov","year":"2025","unstructured":"Kerimkulov A, et al. Efficacy of preventive pressurized intraperitoneal aerosol chemotherapy in patients with locally advanced gastric cancer: protocol for a prospective controlled trial. JMIR Res Protoc. 2025;14:e78053. https:\/\/doi.org\/10.2196\/78053. (PMID: 41218205.).","journal-title":"JMIR Res Protoc"},{"key":"4422_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.suronc.2020.08.012","volume":"35","author":"A Taibi","year":"2020","unstructured":"Taibi A, et al. Systematic review of patient reported outcomes (PROs) and quality of life measures after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Oncol. 2020;35:97\u2013105. https:\/\/doi.org\/10.1016\/j.suronc.2020.08.012. (Epub 2020 Aug 20. PMID: 32862112.).","journal-title":"Surg Oncol"},{"key":"4422_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.suronc.2020.08.012","volume":"35","author":"Z Li","year":"2022","unstructured":"Li Z, Taibi A, Grass F, et al. A systematic review on quality of life (QoL) of patients with peritoneal metastasis (PM) who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC). Pleura Peritoneum. 2022;35:97\u2013105. https:\/\/doi.org\/10.1016\/j.suronc.2020.08.012. (Epub 2020 Aug 20. PMID: 32862112).","journal-title":"Pleura Peritoneum"},{"key":"4422_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejso.2020.08.020","volume":"47","author":"A Taibi","year":"2021","unstructured":"Taibi A, Grass F, Sgarbura O, Pache B, Hubner M, Demartines N. Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC): still standardized or on the verge of diversification? Eur J Surg Oncol. 2021;47:149\u201355.","journal-title":"Eur J Surg Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04422-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04422-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04422-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:02:05Z","timestamp":1792803725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04422-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["4422"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04422-5","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a scoping review of published literature and did not involve human participants, animal subjects, or the collection of personal data. Accordingly, ethical approval was not required. All data analysed were obtained from previously published studies conducted in accordance with the ethical standards of the respective institutional and national research committees.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Artificial intelligence tools (Claude, Anthropic) were used to assist with literature search aggregation and data organisation. All AI-generated content was critically reviewed, verified, and substantially rewritten by the authors, who take full responsibility for the accuracy, interpretation, and integrity of the final manuscript. AI tools were not listed as the authors, in accordance with ICMJE recommendations.","order":3,"name":"Ethics","label":"Use of artificial intelligence","group":{"name":"EthicsHeading","label":"Declarations"}}]}}